Nanomedicines in the treatment of brain tumors

Funmilola A Fisusi^{1

2}, Andreas G Schätzlein^{1

3}, Ijeoma F Uchegbu^{1

3}

Affiliations

¹ UCL School of Pharmacy, 29-39 Brunswick Square, London, WC1N 1AX, UK.
² Drug Research & Production Unit, Faculty of Pharmacy, Obafemi Awolowo University, Ile-Ife, Nigeria.
³ Nanomerics Ltd., New Bridge Street House, 30-34 New Bridge Street, London, EC4V 6BJ, UK.

Funmilola A Fisusi et al. Nanomedicine (Lond). 2018 Mar.

. 2018 Mar;13(6):579-583.

doi: 10.2217/nnm-2017-0378. Epub 2018 Jan 29.

Funmilola A Fisusi^{1

2}, Andreas G Schätzlein^{1

3}, Ijeoma F Uchegbu^{1

3}

¹ UCL School of Pharmacy, 29-39 Brunswick Square, London, WC1N 1AX, UK.
² Drug Research & Production Unit, Faculty of Pharmacy, Obafemi Awolowo University, Ile-Ife, Nigeria.
³ Nanomerics Ltd., New Bridge Street House, 30-34 New Bridge Street, London, EC4V 6BJ, UK.

No abstract available

Keywords: brain tumor; doxorubicin; glioblastoma; nanomedicine; nanoparticle; paclitaxel; theranostic.

MeSH terms